LYEL vs NFLX · rev $6.0K vs P/E 25, rev $12.56B
Lyell Immunopharma Inc (LYEL) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
LYEL currently screens at market cap $143.5M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the LYEL and NFLX stock pages for the full models.
Not investment advice.